These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 4356001)

  • 1. Immune enhancement of pulmonary bactericidal activity in murine virus pneumonia.
    Jakab GJ; Green GM
    J Clin Invest; 1973 Nov; 52(11):2878-84. PubMed ID: 4356001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of Sendai virus infection on bactericidal and transport mechanisms of the murine lung.
    Jakab GJ; Green GM
    J Clin Invest; 1972 Aug; 51(8):1989-98. PubMed ID: 4341012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors influencing the immune enhancement of intrapulmonary bactericidal mechanisms.
    Jakab GJ
    Infect Immun; 1976 Aug; 14(2):389-98. PubMed ID: 9364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung defenses against viral and bacterial challenges during immunosuppression with cyclophosphamide in mice.
    Jakab GJ; Warr GA
    Am Rev Respir Dis; 1981 May; 123(5):524-8. PubMed ID: 6263138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defect in intracellular killing of Staphylococcus aureus within alveolar macrophages in Sendai virus-infected murine lungs.
    Jakab GJ; Green GM
    J Clin Invest; 1976 Jun; 57(6):1533-9. PubMed ID: 180054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pulmonary response to a bacteremic challenge.
    Harrow EM; Jakab GJ; Brody AR; Green GM
    Am Rev Respir Dis; 1975 Jul; 112(1):7-16. PubMed ID: 1096694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminophylline-induced suppression of pulmonary antibacterial defenses.
    Nelson S; Summer WR; Jakab GJ
    Am Rev Respir Dis; 1985 Jun; 131(6):923-7. PubMed ID: 3890643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hypersensitivity pneumonitis on the pulmonary defense mechanisms of guinea pig lungs.
    Jakab GJ; Green GM
    Infect Immun; 1973 Jan; 7(1):39-45. PubMed ID: 4632134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary defense mechanisms in consolidated and nonconsolidated regions of lungs infected with Sendai virus.
    Jakab GJ; Green GM
    J Infect Dis; 1974 Mar; 129(3):363-7. PubMed ID: 4361249
    [No Abstract]   [Full Text] [Related]  

  • 10. Adverse effect of a cigarette smoke component, acrolein, on pulmonary antibacterial defenses and on viral-bacterial interactions in the lung.
    Jakab GJ
    Am Rev Respir Dis; 1977 Jan; 115(1):33-8. PubMed ID: 835891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary defense mechanisms and the interaction between viruses and bacteria in acute respiratory infections.
    Jakab GJ
    Bull Eur Physiopathol Respir; 1977; 13(1):119-35. PubMed ID: 321050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of aerosol immunization with RE 595 Salmonella minnesota on lung bactericidal activity against Serratia marcescens, Enterobacter cloacae, and Pseudomonas aeruginosa.
    LaForce FM
    Am Rev Respir Dis; 1977 Aug; 116(2):241-9. PubMed ID: 407823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Native flagellin does not protect mice against an experimental Proteus mirabilis ascending urinary tract infection and neutralizes the protective effect of MrpA fimbrial protein.
    Scavone P; Umpiérrez A; Rial A; Chabalgoity JA; Zunino P
    Antonie Van Leeuwenhoek; 2014 Jun; 105(6):1139-48. PubMed ID: 24771125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of primary immunization on pulmonary clearance of nontypable Haemophilus influenzae.
    McGehee JL; Radolf JD; Toews GB; Hansen EJ
    Am J Respir Cell Mol Biol; 1989 Sep; 1(3):201-10. PubMed ID: 2624760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. THE ROLE OF THE ALVEOLAR MACROPHAGE IN THE CLEARANCE OF BACTERIA FROM THE LUNG.
    GREEN GM; KASS EH
    J Exp Med; 1964 Jan; 119(1):167-76. PubMed ID: 14113111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythromycin-induced suppression of pulmonary antibacterial defenses. A potential mechanism of superinfection in the lung.
    Nelson S; Summer WR; Terry PB; Warr GA; Jakab GJ
    Am Rev Respir Dis; 1987 Nov; 136(5):1207-12. PubMed ID: 3314615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune impairment of alveolar macrophage phagocytosis during influenza virus pneumonia.
    Jakab GJ
    Am Rev Respir Dis; 1982 Nov; 126(5):778-82. PubMed ID: 7149441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variations in pulmonary antibacterial defenses among experimental animals.
    Jakab GJ; Green GM
    Infect Immun; 1975 Mar; 11(3):601-2. PubMed ID: 1090537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sources of variance in the measurement of intrapulmonary killing of bacteria.
    Ruppert D; Jakab GJ; Sylwester DL; Green GM
    J Lab Clin Med; 1976 Mar; 87(3):544-58. PubMed ID: 765417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential virus infections, bacterial superinfections, and fibrogenesis.
    Jakab GJ
    Am Rev Respir Dis; 1990 Aug; 142(2):374-9. PubMed ID: 2166456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.